Stock listing

NASDAQ:SGTX Sigilon Therapeutics Inc Stock

Follow Sigilon Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:SGTX

$22.47 USD

Close on Aug 11, 2023 · No longer trades

May 23, 2023 to last close +207.4% · daily closes, May 23, 2023 – Aug 11, 2023
Lowest – highest close
$3.91 – $23.06 USDSince May 23, 2023 · lowest Jun 23, 2023 · highest Aug 9, 2023

Delisted NASDAQ:SGTX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:SGTX
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Sigilon Therapeutics Inc on 6ix

Decks
6 decks · latest Mar 14, 2023

Decks

DeckKindSlidesDate
Investor Presentation (March 2023)Investor deck24 slidesMar 14, 2023
Corporate Update (November 2022)Corporate update29 slidesNov 10, 2022
Investor Presentation (October 2022)Investor deck21 slidesOct 11, 2022
Investor Presentation (March 2022)Investor deck28 slidesMar 14, 2022
Q2 2021 Earnings PresentationEarnings30 slidesAug 10, 2021
Corporate Update (May 2021)Corporate update21 slidesMay 10, 2021

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Douglas G Cole
Other companies: Foghorn Therapeutics Inc. (Director · Since at least Oct 22, 2020); Sana Biotechnology, Inc. (Director · Feb 3, 2021 – Jun 6, 2024 · Past); Denali Therapeutics Inc. (Director · Dec 7, 2017 – Jun 1, 2023 · Past); Quanterix Corporation (Director · Dec 6, 2017 – Jan 2, 2019 · Past); Editas Medicine, Inc. (Director · Feb 2, 2016 – Aug 17, 2017 · Past); Agios Pharmaceuticals, Inc. (Director · Jul 23, 2013 – Aug 10, 2016 · Past); Receptos Inc (Director · May 8, 2013 – Jul 17, 2013 · Past); Tetraphase Pharmaceuticals Inc (Director · Mar 19, 2013 – Mar 25, 2013 · Past); AVEO Pharmaceuticals Inc (Director · Mar 11, 2010 – May 12, 2011 · Past)
Director · Dec 3, 2020 – Aug 11, 2023 · Past
Coelho Rogerio Vivaldi
Other companies: Viatris Inc. (Director · Since at least Jun 3, 2024); Crinetics Pharmaceuticals, Inc. (Director · Since at least Jan 3, 2022); Bioverativ Inc (EVP, Chief Global Therapeutics · Dec 22, 2016 – Mar 8, 2018 · Past); Spark Therapeutics Inc (Chief Commercial Officer · Jan 29, 2015 – Jul 15, 2016 · Past); Minerva Neurosciences, Inc (President and CEO, Director · Jun 30, 2014 – Jun 30, 2014 · Past)
PRESIDENT AND CEO, Director · Dec 3, 2020 – Aug 11, 2023 · Past
John Cox
Other companies: Dyne Therapeutics, Inc. (President and Chief Executive Officer · Since at least Mar 25, 2024); Bioverativ Inc (Chief Executive Officer, Director · Dec 22, 2016 – Mar 8, 2018 · Past); Repligen Corporation (Director · Nov 15, 2013 – Mar 24, 2020 · Past); Biogen Inc. (EVP Pharmaceutical Oper & Tech · Nov 1, 2011 – Apr 1, 2016 · Past)
Director · Dec 3, 2020 – Aug 11, 2023 · Past
Kavita Patel
Other companies: Arcellx Inc (Director · Since at least Feb 3, 2022); SelectQuote, Inc. (Director · Since at least Sep 23, 2020); Intelligent Medicine Acquisition Corp (Director · Nov 4, 2021 – Nov 4, 2021 · Past)
Director · Dec 3, 2020 – Aug 11, 2023 · Past
Brooke Story
Other companies: PolyPid Ltd. (Chairman of the Board · Since at least Dec 16, 2025); LivaNova PLC (Director since 2022 · Since at least Sep 15, 2022)
Director · Jun 14, 2021 – May 26, 2022 · Past
Glenn Reicin
Other companies: Harmony Biosciences Holdings, Inc. (Chief Financial Officer · Since at least Apr 14, 2026); Jasper Therapeutics, Inc. (Director · Nov 19, 2019 – Nov 19, 2019 · Past)
CHIEF FINANCIAL OFFICER · Dec 3, 2020 – Feb 11, 2021 · Past
Matthew P. Kowalsky
Other companies: Enanta Pharmaceuticals, Inc. (Chief Legal Officer · Since at least Apr 29, 2024); Protara Therapeutics, Inc. (VP, Legal and Secretary · Apr 27, 2017 – Jan 18, 2019 · Past)
CHIEF OF STAFF AND CLO · Feb 28, 2023 – Aug 11, 2023 · Past
Daniel Griffith AndersonDirector · Dec 3, 2020 – Jun 2, 2021 · Past
Josias PontesCHIEF FINANCIAL OFFICER · Jun 14, 2021 – Aug 11, 2023 · Past

Open People

Log in to ask 6ix AI your own questions about Sigilon Therapeutics Inc.